The concentration-dependent effects of echinocandins on the metabolic activity of Aspergillus spp. were comparatively studied by using nongerminated and germinated conidia. The susceptibilities of 11 Aspergillus fumigatus, 8 A. terreus and 8 A. flavus isolates to caspofungin, micafungin, and anidulafungin were studied by a CLSI (formerly NCCLS) M38-A broth microdilution-based method. After 48 h of incubation the minimum effective concentration (MEC) was defined microscopically. Metabolic activity was assessed by the 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide assay and modeled by using the sigmoid (E max ) or "bell-shaped" model. The median MEC values of caspofungin (0.5 to 1 g/ml), micafungin (0.06 to 0.12 g/ml), and anidulafungin (0.03 g/ml) against nongerminated conidia increased by 0 to 1, 1 to 2, and 2 to 3 twofold dilutions, respectively (depending on the species), over those against germinated conidia. A similar shift to the right was demonstrated for the corresponding curves of metabolic activity. There was a significant correlation between the degrees of maximal metabolic inhibition caused by different echinocandins at both the species level (greater inhibition for A. flavus) and the strain level (r ‫؍‬ 0.84 to 0.93; P < 0.0001). Paradoxical increases in metabolism in the presence of higher concentrations of caspofungin, micafungin, and anidulafungin were detected in 6, 2, and 5 of the A. fumigatus  isolates, respectively; 5, 1, and 2 of the A. terreus isolates, respectively; and 1, 0, and 0 of the A. flavus isolates,  respectively. Based on the model, 50% of the maximal paradoxical increase was detected with 4.2, 11.1, and 10 .8 g/ml of caspofungin, micafungin, and anidulafungin, respectively. All echinocandins therefore exerted comparable levels of maximal metabolic inhibition against Aspergillus spp. at concentrations that were differentially increased for germinated versus nongerminated conidia. The paradoxical increase in metabolism occurred more frequently and at lower concentrations with caspofungin than with micafungin and anidulafungin. Species (no. of strains) Conidial state Median (range) Y min (%) Caspofungin a Micafungin a Anidulafungin b A. fumigatus (
The echinocandins are a group of recently introduced cyclic lipopeptide agents that inhibit the (1,3)-␤-D-glucan synthase activity of Candida spp. and Aspergillus spp. (10) . In vitro and at clinically relevant concentrations, these compounds do not usually cause the complete inhibition of Aspergillus growth but induce morphological hyphal changes. The minimum effective concentration (MEC), defined as the lowest drug concentration at which short, stubby, and highly branched hyphae are observed, has been introduced for the determination of echinocandin activity against Aspergillus spp. in vitro (3, 13, 16, 24) . The MEC, however, represents a subjective, qualitative assessment of hyphal morphology and does not provide a quantification of the antifungal activity at different concentrations.
We recently developed a new, objective, and quantitative method for assessment of the in vitro activity of caspofungin against Aspergillus fumigatus, A. terreus, and A. flavus by measuring the drug-induced changes in the metabolic activities of these species by using an optimized 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay (1) . This method generated descriptive concentration-effect curves of the activity of caspofungin against Aspergillus spp. and demonstrated inter-and intraspecies differences in the degrees of metabolic inhibition associated with the formation of aberrant hyphae. This inhibition was greater for A. flavus than for the other two species. For almost half of the A. fumigatus and A. terreus isolates, a paradoxical increase in metabolism was detected at higher caspofungin concentrations. These concentration-dependent metabolic changes in the absence and the presence of the paradoxical response were described by using the sigmoid (E max ) and "bell-shaped" models, respectively, and the 50% effective concentrations (EC 50 s) generated by these models were a good approximation of the microscopically defined MEC (1) .
While the mechanisms and potential in vivo and clinical significance of the concentration-dependent effects against Aspergillus spp. revealed above remain to be investigated, it would be important to discern whether these effects are caspofungin specific or are shared with the other echinocandins. Of particular interest would be an investigation of whether those species and isolates with lower degrees of metabolic inhibition by caspofungin are less inhibited by the other echinocandins as well (i.e., if there is metabolic cross-resistance among these agents), whether the EC 50 values generated by the model also approximate the microscopic MECs of micafungin and anidulafungin, and whether the paradoxical increase in metabolism is observed for these echinocandins as well. Notably, recent stud-ies on the paradoxical effect of caspofungin against Candida spp. suggested that this was less frequently observed with other echinocandins (7, 29) .
We therefore comparatively studied the in vitro activities of caspofungin, micafungin, and anidulafungin against a large collection of A. fumigatus, A. terreus, and A. flavus isolates using the quantitative methodology described above. These studies were performed with both nongerminated and germinated conidia in order to investigate the possibility of the partial attenuation of activity for some or all of these compounds under circumstances in which they are added after the germination of Aspergillus conidia, which is the most likely scenario in vivo.
MATERIALS AND METHODS

Isolates.
A total of 27 clinical isolates of Aspergillus spp. were used, including 11 isolates of A. fumigatus, 8 of A. terreus, and 8 of A. flavus. The conidia were harvested after the isolates were subcultured on potato dextrose agar at 35°C for 5 to 7 days and were suspended in normal saline containing 0.025% Tween 20. The conidial suspensions were counted with a hemacytometer (27) , and the inoculum sizes were verified by quantitative colony counts on Sabouraud dextrose agar plates. Reference strains Candida krusei ATCC 6258 and Candida parapsilosis ATCC 22019 were used as quality controls.
Medium. RPMI 1640 medium with L-glutamine but without bicarbonate, buffered to pH 7.0 with 0.165 M 3-N-morpholinopropanesulfonic acid (Cambrex Bio Science, Walkersville, MD), was used as the assay medium.
XTT and menadione. The tetrazolium salt XTT (Sigma-Aldrich, St. Louis, MO) was dissolved in normal saline at 0.5 mg/ml. Menadione (Sigma-Aldrich) was dissolved in absolute ethanol at 10 mg/ml (58 ϫ 10 Ϫ3 M) and was subsequently added to the XTT solution at a concentration of 31.25 M.
Susceptibility testing. The susceptibilities of all Aspergillus isolates to caspofungin, micafungin, and anidulafungin were studied by a broth microdilution method based on the recommendations in CLSI (formerly NCCLS) document M38-A (23), with minor changes. Caspofungin (Merck & Co. Inc., Whitehouse Station, NJ), micafungin (Astellas Pharma US Inc., Deerfield, IL), and anidulafungin (Vicuron Pharmaceuticals Inc., distributed by McKesson Bioservices, Rockville, MD) were dissolved in normal saline. Twofold serial dilutions of these agents in 100 l of the assay medium were initially prepared in flat-bottom 96-well microtitration plates (Costar 3596; Corning Inc., Corning, NY) in order to obtain final concentrations of caspofungin ranging from 0.015 to 16 g/ml at a total volume of 200 l after addition of the fungal inoculum. For micafungin and anidulafungin, the concentrations studied were 0.008 to 2 and 8 and 16 g/ml, respectively. For those isolates demonstrating a paradoxical increase in metabolic activity at higher drug concentrations (see Results), three additional concentrations (32, 64, and 128 g/ml) of all the echinocandins were studied.
For the studies with the nongerminated conidia, 100 l of medium containing 5 ϫ 10 4 conidia/ml were added to the drug-containing wells described above, yielding a final concentration of 2.5 ϫ 10 4 conidia/ml, and the plates were incubated at 37°C for 48 h. The MEC was then defined microscopically by two of the investigators (C.A. and J.M.) as the lowest drug concentrations that produced short, stubby, and highly branched hyphae (3, 13) . In case discordant MEC values were found, the highest concentration was reported.
For the studies with the germinated conidia, plates with 100 l of medium/well containing 5 ϫ 10 4 conidia/ml were incubated at 37°C for 10 h for the A. fumigatus and A. flavus isolates and for 15 h for the A. terreus isolates, based on the findings of preliminary germination studies demonstrating Ͼ90% germination for all isolates after these incubation periods. Subsequently, 100 l of the twofold drug dilutions prepared as described above was added to each well in order to yield the desired final concentrations, as described above for the nongerminated conidia. After further incubation for 48 h with the drug at 37°C, the MEC was defined microscopically, as described above.
For each of the three echinocandins, a row of wells with drug dilutions was filled with medium up to a total volume of 200 l, without the fungal inoculum, and served to provide the background absorbance values in subsequent spectrophotometric measurements of the absorbance of XTT.
In order to eliminate the possible effects of the inoculum or the drug concentration or the possible effects of variations in the comparisons of the three echinocandins or the nongerminated and the germinated conidia, for each Aspergillus isolate the same inoculum preparation was used for comparative studies of all three echinocandins against the nongerminated and the germinated conidia. In addition, for each echinocandin, the same drug dilution preparations were used for studies of nongerminated versus germinated conidia. The experiments were repeated in triplicate.
Metabolic assay. The concentration-dependent effects of caspofungin, micafungin, and anidulafungin on the metabolic activities of the Aspergillus spp. were comparatively studied by using the optimized XTT assay developed previously (1) . Briefly, immediately after determination of the MECs for all three echinocandins against nongerminated or germinated conidia, 50 l of the XTT-menadione solution described above was added to each well, resulting in final concentrations of 100 g/ml XTT and 6.25 M menadione. The plates were incubated at 37°C for 2 h and were subsequently shaken for 1 to 2 min (Plate Shake 1296-004; Wallac OY, Turku, Finland) for further dissolution of the formazan derivatives. The color absorbance (A) was then measured at dual wavelengths (450 nm, with a reference wavelength of 630 nm) with a microtitration plate spectrophotometric reader (Elx808; Bio-Tek Instruments, Winooski, VT). The percent metabolic activity (Y) for each well with drug in relation to that of the drug-free control well was calculated, after subtraction of the background absorbance, as [(A drug well Ϫ A background drug well )/(A control Ϫ A background control )] ϫ 100.
In cases in which a paradoxical increase in metabolic activity was observed at higher drug concentrations for some isolates, it was considered significant if it exceeded the minimum metabolic activity detected at lower concentrations (usually at the MEC or 1 to 2 dilutions higher) by at least 40% and was consistent in all three experiments (1, 20) .
Modeling of in vitro echinocandin activities against Aspergillus spp. Nonlinear regression analysis of the data was applied by including all three replicate Y values as individual points in the same fitting process. This resulted in a single estimated parameter value for each isolate. No weighting was applied. For those isolates for which a paradoxical response was not detected, the E max model (sigmoid curve with variable slope) was used. The E max model is described by the equation
where X is the log 10 drug concentration. The four parameters generated by the model are the values of the maximum Y (Y max ) and the minimum Y (Y min ); EC 50 , which is the drug concentration that shows metabolic activity that is halfway between Y max and Y min [i.e., Y min ϩ 0.5 ⅐ (Y max Ϫ Y min )]; and the slope, which describes the steepness of the curve (22) . For every isolate, the EC 5 value was also calculated. EC 5 is the drug concentration showing metabolic activity equal to
From equations 1 and 2 and by solving for X, EC 5 was calculated as described previously (2): EC 5 ϭ 10 ͓loga/͑1 Ϫ a͔͒/slope ϩ log EC50 , where a is equal to 0.05.
The bell-shaped model was used for those isolates demonstrating a paradoxical increase in metabolic activity at higher drug concentrations, after appropriate initial values were chosen. This model is described by the
The biphasic curve begins at Y max 1, turns over at Y min , and then approaches Y max 2. EC 50 1 and EC 50 2 are the corresponding EC 50 values, respectively, and n H 1 and n H 2 are the corresponding slope factors, respectively, for each phase of the curve. As shown in the equation presented above, the bell-shaped model combines two sigmoid concentrationeffect relationships and, despite its name, does not describe a normal distribution. Instead, the bell-shaped equation is appropriate for the description of asymmetric biphasic concentration-effect curves (1, 21) . For every isolate for which the bell-shaped model was used, the EC 5 1 value (i.e., the EC 5 value corresponding to the first [descending] phase of the curve) was also calculated, based on the following equation: EC 5 1 ϭ 10 log͓a/͑1 Ϫ a͔͒/nH1 ϩ log EC501 , where a is equal to 0.05. The goodness of fit for both models was assessed by the determination of R 2 values, the runs test, and visual inspection. Model building was performed by using Prism software (version 4.0b; GraphPad, San Diego, CA).
Statistical analysis. Comparisons of the MECs and model-derived quantitative parameters (EC 5 , Y min , slope) were made between (i) the three echinocandins for each species, (ii) the three Aspergillus species for each drug, and (iii) germinated and nongerminated conidia for each species and drug. Differences were assessed after log 10 transformation of the values and by passing Bartlett's test for equal variances by one-way analysis of variance, followed by Bonferroni's posttest. In case normality was not restored after log 10 transformation of the values or the variances differed significantly according to Bartlett's test, the differences described above were assessed by using the nonparametric Kruskal-Wallis test, followed by Dunn's test for multiple comparisons. The correlation among the Y min values obtained with the three echinocandins for each Aspergillus isolate was assessed with the Pearson correlation coefficient if the values obtained had a normal distribution, based on the D'Agostino and Pearson omnibus normality test, or with the Spearman nonparametric correlation coefficient if the values did not pass the normality test. Statistical analysis also was performed by using GraphPad Prism software (version 4.0b).
RESULTS
Susceptibility testing.
Of the three echinocandins studied, anidulafungin exhibited the lowest MEC values and caspofungin exhibited the highest MEC values against nongerminated conidia of Aspergillus spp. (P was Ͻ0.01 for all comparisons) ( Table 1) . Against germinated Aspergillus conidia, however, micafungin and anidulafungin had comparable MEC values, and these were lower than those of caspofungin. Differences between the echinocandins in the changes in the MEC values in the presence of germinated and nongerminated conidia were observed; while for caspofungin the MEC remained unchanged or increased by a maximum of 1 twofold dilution, for anidulafungin the MEC increased by a median of 2 to 3 dilutions, depending on the Aspergillus spp. For micafungin the MEC increased by a median of 1 dilution for A. fumigatus and A. terreus and 2 dilutions for A. flavus (Table 1) . On microscopic examination, the transition from normal to short, stubby, and highly branched hyphae in the presence of increasing drug concentrations was found to occur more gradually for micafungin (often over a range of 3 to 4 drug dilutions) than for the other two echinocandins with both nongerminated and germinated conidia.
Concentration-dependent effects of echinocandins on Aspergillus spp. A substantial decrease in metabolic activity associated with the formation of short, aberrant hyphae was observed for all Aspergillus isolates in the presence of increasing concentrations of any of the three echinocandins. These metabolic properties are exemplified in Fig. 1 . Of the total 81 drug-isolate pairs (3 echinocandins ⅐ 27 isolates) studied with both nongerminated and germinated conidia, these concentration-dependent effects were described with the E max model in 59 drug-isolate pairs for nongerminated conidia (median R 2 , 0.96; R 2 range, 0.81 to 0.99) and germinated conidia (median R 2 , 0.94; R 2 range, 0.75 to 0.98). The bell-shaped model described the metabolic changes in the remaining 22 drug-isolate pairs for nongerminated conidia (median R 2 , 0.96; R 2 range, 0.83 to 0.99) and germinated conidia (median R 2 , 0.93; R 2 range, 0.76 to 0.99). No significant deviation from the models was detected by use of the runs test. In most cases, the 95% confidence intervals provided by the models for the EC 50 and the EC 5 values were Ͻ1 log 2 , while for the Y min values, Y max values, and slopes, the ratio of the standard error to the best-fit value was Ͻ35%. In cases in which wider 95% confidence intervals or greater standard errors were obtained, however, the values generated by the models were not excluded from the conidia) in the presence of increasing concentrations of caspofungin, micafungin, and anidulafungin. For caspofungin and anidulafungin, the curves were generated with the bell-shaped model, and for micafungin, the curves were generated with the E max model. The parameters calculated by the models, as well as the microscopically defined MECs, are presented. analysis, as they still represented the best estimate for the parameters of interest. Slopes and EC 5 values. Of the three echinocandins studied, the steepest concentration-effect curves were obtained for caspofungin, with median slopes of Ϫ4.94 for nongerminated conidia and Ϫ6.67 for germinated conidia; and the shallowest curves were obtained for micafungin, with median slopes of Ϫ2.42 and Ϫ2.15 for nongerminated and germinated conidia, respectively (P Ͻ 0.001). Anidulafungin curves had intermediate slopes, with median values of Ϫ3.91 for nongerminated conidia and Ϫ3.37 for germinated conidia. These differences in the steepnesses of the curves among the three echinocandins correlated inversely with the distance between the MEC values defined microscopically and the corresponding EC 50 or EC 50 1 values generated with the E max or bell-shaped model (Fig. 1) .
The median differences between the MEC and the EC 50 or EC 50 1 values for nongerminated and germinated conidia were 1.02 and 0.64 twofold dilutions, respectively, for caspofungin; 2.43 and 3.40 dilutions, respectively, for micafungin; and 2.03 and 2.15 dilutions, respectively, for anidulafungin. Conse-quently, while the EC 50 or EC 50 1 values provided a good approximation of the MEC for caspofungin, they tended to be 2 or more dilutions less than the MECs of micafungin and anidulafungin. In contrast, the EC 5 or EC 5 1, which corresponded to a percentage of metabolic activity that was much closer to the Y min than the EC 50 or EC 50 1, approximated the MECs for all three echinocandins, as the median differences between the MEC and the EC 5 or EC 5 1 values for nongerminated and germinated conidia were 0.006 and Ϫ0.11 dilution, respectively, for caspofungin; 0.48 and 1.55 dilutions, respectively, for micafungin; and 0.68 and 0.90, respectively, for anidulafungin. Consistent with the proximity of the modelderived EC 5 (or EC 5 1) and microscopically defined MEC values was the fact that the differences in EC 5 (or EC 5 1) values between echinocandins for germinated and nongerminated conidia paralleled the differences in the MEC values ( Table 2) .
Maximal metabolic inhibition (Y min ) of Aspergillus spp. The degree of maximal metabolic inhibition of Aspergillus spp. by the three echinocandins, manifested by the Y min values generated with the E max or bell-shaped model, presented in Table 3 . 10% ), suggesting that the degree of metabolic inhibition induced by the echinocandins was not significantly altered in the presence of germinated conidia in comparison to that in the presence of nongerminated conidia. For the same species (nongerminated and germinated conidia), the medians and ranges of the Y min values obtained in the presence of each of the three echinocandins were comparable (Table 3) . Moreover, a significant correlation of the Y min values obtained for each Aspergillus isolate was demonstrated among the echinocandins. For example, the relationship between Y min A and Y min B for two isolates (A and B, respectively) of A. terreus was preserved across all three echinocandins (Fig. 2) .
When all isolates (nongerminated conidia) were grouped together, the correlation coefficients were 0.84 for the Y min values of micafungin compared with those of caspofungin, 0.92 for anidulafungin compared with those of caspofungin, and 0.93 for anidulafungin compared with those of micafungin (P Ͻ 0.0001) (Fig. 3) . This correlation could be demonstrated even when the species with the greater variation in Y min values (A. fumigatus, A. terreus) were analyzed separately. For A. fumigatus, the coefficients ranged from 0.84 to 0.91 (P Ͻ 0.001) for correlations between all three echinocandins; for A. terreus, the coefficients ranged from 0.91 to 0.98 (P Ͻ 0.004). The correlation in the degrees of metabolic inhibition among the three echinocandins also persisted for germinated conidia, with coefficients ranging from 0.81 to 0.88 (P Ͻ 0.0001) for the Y min values of all Aspergillus isolates, 0.72 to 0.94 (P Ͻ 0.03) for A. fumigatus, and 0.82 to 0.94 (P Ͻ 0.02) for A. terreus isolates.
Paradoxical increase in metabolic activity. A paradoxical increase in the metabolic activity of nongerminated and germinated Aspergillus conidia in the presence of higher drug concentrations was detected for caspofungin in six and seven of the A. fumigatus isolates, respectively; five and five of the A. terreus isolates, respectively; and one and zero of the A. flavus isolates, respectively. Some, but not all, of these isolates exhibited this phenomenon for the other two echinocandins as well. In particular, for micafungin with nongerminated and germinated conidia, it was detected in two and one of the A. fumigatus isolates, respectively; one and one of the A. terreus isolates, respectively; and zero and zero of the A. flavus isolates, respectively. For anidulafungin with nongerminated and germinated conidia, it was detected in five and six of the A. fumigatus isolates, respectively; two and two of the A. terreus isolates, respectively; and zero and zero of the A. flavus isolates, respectively. In most cases, the paradoxical response obtained with germinated conidia was observed for those isolates for which it was observed with nongerminated conidia, as suggested by the on January 31, 2020 by guest http://aac.asm.org/ small differences in the corresponding numbers. Examination of the wells under an inverted microscope suggested that the paradoxical increase in metabolic activity was associated with the progressive elongation of the aberrant hyphae at higher drug concentrations compared to the increase observed at the MEC (Fig. 4) . By subtracting the Y min value from the Y max 2 value generated with the bell-shaped model for those isolates demonstrating the paradoxical response, the increases in the percentages of metabolic activity at higher concentrations were comparable for the three echinocandins, with median increases of 23% (range, 6% to 38%) for caspofungin, 16% (range, 14% to 35%) for micafungin, and 29% (range, 18% to 35%) for anidulafungin (for the nongerminated conidia). However, the second (ascending) parts of the bell-shaped curves, associated with the paradoxical increase in fungal metabolism, were shallower for micafungin and anidulafungin (median n H 2 values, Ϫ1.92 and Ϫ1.47, respectively) than those of caspofungin (median n H 2 value, Ϫ3.13) (see also Fig. 1 and 2) . In agreement with this finding, the EC 50 2 values of micafungin (median, 11.1 g/ml; range, 1.78 to 16.7 g/ml) were comparable to those of anidulafungin (median, 10.8 g/ml; range, 1.3 to 19.1 g/ml) but higher than those of caspofungin (median, 4.2 g/ml; range, 0.5 to 17.8 g/ml). These results suggest that the paradoxical effect occurred at higher concentrations for micafungin and anidulafungin than for caspofungin. Furthermore, considering the lower MEC and EC 5 1 or EC 50 1 values obtained for micafungin and anidulafungin than those obtained for caspofungin (Tables 1 and 2) , it became apparent that the difference between the concentrations at which the echinocandins exerted the paradoxical effect (EC 50 2) and those concentrations at which they induced the formation of aberrant hyphae (MEC, EC 5 1, EC 50 1) was considerably greater for micafungin and anidulafungin than for caspofungin. Indeed, the median differences between the EC 50 2 and the EC 50 1 values for micafungin and anidulafungin were 9.4 and 9.8 twofold drug dilutions, respectively, while for caspofungin the median difference was only 3.5 drug dilutions.
Finally, for all isolates that were further studied by using echinocandin concentrations that exceeded those achieved at currently approved dosages (32, 64, and 128 g/ml), a marked decrease in fungal metabolism was observed at 64 or 128 g/ml of caspofungin, resulting in Ͻ5% metabolic activity and the absence of visual growth (MIC-0) at 128 g/ml. In contrast, no inhibition of growth or a significant reduction of metabolism was detected at 64 or 128 g/ml for the other two echinocandins, for which the percent metabolic activity remained at or close to the Y max 2 values.
DISCUSSION
The present study comparatively investigated the in vitro activities of echinocandins against nongerminated and germinated Aspergillus conidia by using, besides the MEC, a previously optimized metabolic assay (1) that provides quantification of the concentration-dependent drug effects and, therefore, more information over a range of concentrations. Previous comparative studies of the in vitro activities of echinocandins against Aspergillus spp. have used the MEC endpoint (12, 26, 28) ; in addition, the activities of these agents against germinated conidia have not heretofore been systematically assessed.
The transition from normal to short, stubby, and highly branched hyphae was observed to occur more gradually with micafungin than with the other two echinocandins, a fact that could potentially increase the subjectivity in MEC determination. These microscopic findings correlated with the differences in the steepnesses of the concentration-effect curves of metabolic activity among the echinocandins, with caspofungin having the steepest curves and micafungin having the shallowest curves. Consequently, the EC 5 or EC 5 1 value, which corresponded to a percent metabolic activity that was much closer to the Y min than the EC 50 or EC 50 1, was the model-derived parameter that approximated the MEC for all three echinocandins. A plausible explanation for the shallower metabolic curves for micafungin and anidulafungin could be that these echinocandins may exhibit a more gradual concentration-dependent access or binding to their fungal cell target than caspofungin. This postulation could be related to the fact that the micafungin and anidulafungin molecules have similar structures in their aromatic side chains, while caspofungin has an aliphatic side chain (18, 31, 33) .
The lower MEC and EC 5 or EC 5 1 values demonstrated in the present study for micafungin and anidulafungin than those for caspofungin are consistent with the findings of other in vitro studies (12, 25, 26, 28) . Previous studies of host defense mechanisms against A. fumigatus have also shown that all three echinocandins have activity against germinated conidia, but there was no direct comparison with their activities against nongerminated conidia (5, 8, 9) . The mechanism for the significant increase in the MEC and the EC 5 or EC 5 1 values in the presence of germinated conidia for anidulafungin and, to a less extent, for micafungin demonstrated here is not fully understood. A simple hypothesis could be that the germinated conidia have a much greater fungal biomass than nongerminated conidia and that the significantly increased amount of (1,3)-␤-D-glucan synthase in germinated conidia cannot be inhibited by the very low anidulafungin or micafungin concentrations that are effective against nongerminated conidia. Notably, the greater increases in the MEC and EC 5 or EC 5 1 values in the presence of germinated conidia were observed for anidulafungin, which had the lowest MEC and EC 5 or EC 5 1 values against nongerminated conidia.
The increases in the MEC and the EC 5 or EC 5 1 values of anidulafungin and micafungin against germinated conidia may have practical implications. First, as calculation of the optimal echinocandin dosages for in vivo or clinical studies may take into consideration the MEC value, this parameter may be more relevant for germinated conidia than for nongerminated conidia. Wiederhold et al. demonstrated that the pharmacokinetic/pharmacodynamic parameter that is the most closely associated with the in vivo efficacy of caspofungin was the peak plasma concentration/MEC ratio (32) . If such a parameter, for example, is to be calculated for anidulafungin or micafungin, then the MEC value, based on our findings, would preferably be that for germinated conidia. Second, the differences in the MEC and the EC 5 or EC 5 1 values for germinated conidia versus those for nongerminated conidia may suggest that anidulafungin has a relatively greater efficacy against Aspergillus infections in the prophylactic setting than in the therapeutic setting.
Significant inter-and intraspecies variations in the maximal percentages of metabolic inhibition of Aspergillus spp. were demonstrated for all echinocandins, with greater inhibition achieved for A. flavus. These results are in agreement with those published previously for caspofungin (1) but appear to be somewhat different from those of two other previous studies, which demonstrated a diminished inhibitory effect of micafungin against A. flavus compared to that against A. fumigatus or A. terreus by the XTT assay (15, 17) . However, in both of those studies, the final concentration of menadione added to the wells was 25 M, i.e., a concentration fourfold higher than the one (6.25 M) used in the present study. We have previously shown that the 25 M menadione concentration may mask the degree of metabolic inhibition caused by the echinocandins against Aspergillus spp. and that the 6.25 M concentration is more appropriate for this purpose (1) . Furthermore, the fluorescence staining for the determination of viability that was additionally performed in one of those studies (17) showed that micafungin caused hyphal damage for A. flavus at least comparable to that for A. fumigatus and A. terreus, in agreement with the findings of the present study.
The inter-and intraspecies differences in the levels of metabolic inhibition of Aspergillus spp. by echinocandins demon-strated here may have in vivo or clinical significance that warrants further investigation. Mice infected with A. flavus appeared to have better survival or microbiological clearance than those infected with A. fumigatus or A. terreus following treatment with caspofungin (4, 6). Maertens et al., in their study of caspofungin as salvage treatment for invasive aspergillosis, reported that microbiological eradication was achieved in 54% of 13 patients with A. flavus infection but only 28% of 47 patients with A. fumigatus infection (19) . In a recent study of micafungin use, alone or in combination with other antifungal agents, for the treatment of invasive aspergillosis, a favorable response was observed in 29.4% of 102 patients with A. fumigatus infection, 48.4% of 31 patients with A. flavus infection, and 0% of 10 patients with A. terreus infection (11) . Although these data may be confounded by a number of factors, the trends observed in those studies are in agreement with our finding of the greater metabolic inhibition of A. flavus than of A. fumigatus or A. terreus in the presence of echinocandins, despite the similar MEC values among these species.
The degrees of maximal metabolic inhibition caused by the echinocandins were comparable at the species and the strain levels, with a significant correlation of the Y min values obtained for each isolate of A. fumigatus and A. terreus (which showed the greatest interspecies variations in metabolic inhibition) in the presence of caspofungin, micafungin, or anidulafungin. This finding may have practical implications if the degree of metabolic inhibition indeed proves to correlate with the in vivo or clinical outcome of echinocandin treatment.
The paradoxical increase in metabolism, which occurred at higher concentrations for some of the A. fumigatus and A. terreus isolates but uncommonly for A. flavus, was associated with the progressive elongation of aberrant hyphae ( Fig. 4) and was detected in decreasing order of frequency with caspofungin, anidulafungin, and micafungin. It seems that a subpopulation of isolates from each species is prone to this phenomenon, which is then variably expressed with the different echinocandins. Possible mechanisms of this paradoxical effect and its uncommon occurrence in A. flavus in the presence of caspofungin have already been described (1, 14, 30) . The differential frequencies among the echinocandins parallel those detected in other studies on the effects of these agents against Candida spp. (7, 29) . Certain comparative features of the activities of the echinocandin described for the inhibitory metabolic effects associated with the transition from normal to aberrant hyphae were also observed for the paradoxical effect. First, the maximal levels of inhibition of metabolism were comparable among the three agents, as were the percentages of increase in metabolic activity at higher concentrations. Second, the slopes of the descending parts of the concentrationeffect curves (describing the inhibition of metabolic activity) were shallower for micafungin and anidulafungin than for caspofungin, as were the slopes for the ascending parts of the curves (describing the paradoxical increase of metabolism at higher concentrations).
The present study therefore revealed certain comparative features of echinocandin in an analysis of the concentrationdependent activities of the echinocandins against Aspergillus spp. Common features among the echinocandins were the comparable degrees of maximal metabolic inhibition at the species level (greater inhibition for A. flavus) and the strain level, as well as the comparable increases in metabolic activity at higher concentrations for isolates demonstrating the paradoxical effect. However, the concentrations of the echinocandins at which metabolic inhibition occurred for Aspergillus spp., as well as the corresponding MEC values, increased differentially for germinated and nongerminated conidia, with a greater increase obtained with anidulafungin and a minimal increase obtained with caspofungin. Shallower metabolic curves were observed for micafungin and anidulafungin, for which the paradoxical increase in metabolism occurred at lower frequencies and at higher concentrations than those of caspofungin.
